General MedicationsORALStandard
CITALOPRAM HYDROBROMIDE
CITALOPRAM HYDROBROMIDE
Standard Dose
EQ 10MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 201450 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CITALOPRAM HYDROBROMIDE Form and strength SOLUTION;ORAL - EQ 10MG BASE/5ML Sponsor HETERO LABS LTD III Submission history Latest submission status date: 2023-08-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 201450 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CITALOPRAM HYDROBROMIDE Form and strength SOLUTION;ORAL - EQ 10MG BASE/5ML Sponsor HETERO LABS LTD III Submission history Latest submission status date: 2023-08-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.